Effective linkage to specialist care, including antiviral treatment, is crucial to maximise the possible health impact of screening. Clear referral pathways should to be central in the design of screening interventions.
In our study in six European countries, we found highly complex and at times ineffective patient pathways. These, along with the complex nature of viral hepatitis, compound other health service-related and patient-side barriers facing migrant groups.
This section is in development and includes good practice examples and recommendations to help ensure linkage to care.